Tech Company Financing Transactions
RevOpsis Therapeutics Funding Round
On 9/16/2025, RevOpsis Therapeutics secured financing from ExSight Ventures.
Transaction Overview
Company Name
Announced On
9/16/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate preclinical development of its lead candidate and expand its pipeline of novel ophthalmic assets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4109 Chandlerwood
Springfield, IL 62711
USA
Springfield, IL 62711
USA
Phone
Undisclosed
Website
Email Address
Overview
Our ophthalmology and antibody development roots go deep. Our team is comprised of doctors, scientists, and business leaders that lead the seminal discovery, development, and commercialization of revolutionary biologics for the treatment of retinal vascular diseases. We are now focusing our Rev-Mod Platform to build a pipeline of multispecific biologics that address unmet needs in opthalmology and to solve blindness worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Ramesh Bhatt
Founder
Ramanath Bhandari
Browse more venture capital transactions:
Prev: 9/16/2025: itselectric venture capital transaction
Next: 9/16/2025: Ethosphere venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs